Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Seelos Therapeutics Inc
SEELCurrent price
0.7 USD
0 USD (0.00%)
Last closed
0.68 USD
Company
seelostherapeutics.com
ISIN
US81577F1093
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
598 430 USD
Yield for 12 month
-99.89 %
1Y
3Y
5Y
10Y
15Y
SEEL
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-004, an gene therapy targeting gene and alpha synuclein; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; SLS-007, a peptidic inhibitor for NACore Parkinson disease; and SLS-009, a protein targeted autophagy for Alzheimer disease. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York. Address: 300 Park Avenue, New York, NY, United States, 10022
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
120 USDP/E ratio
0.0029Dividend Yield
–Current Year
+2 203 000 USD
Last Year
+808 000 USD
Current Quarter
+376 000 USD
Last Quarter
+579 000 USD
Current Year
+2 146 000 USD
Last Year
-53 000 USD
Current Quarter
+361 000 USD
Last Quarter
+564 000 USD
Key Figures SEEL
1 year
3 years
5 years
10 years
EBITDA
-27 706 000 USD
Operating Margin TTM
PE Ratio
0.0029
Return On Assets TTM
-261.11 %
PEG Ratio
–
Return On Equity TTM
-584.2 %
Wall Street Target Price
120 USD
Revenue TTM
2 014 000 USD
Book Value
-135.5 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
11.9 %
Dividend Yield
–
Gross Profit TTM
-46 649 000 USD
Earnings per share
351.04 USD
Diluted Eps TTM
351.04 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
203.13 %
Dividend Analytics SEEL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SEEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:16
Payout Ratio
–
Last Split Date
27.09.2024
Dividend Date
24.01.2019
Stock Valuation SEEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.0029
Forward PE
–
Enterprise Value Revenue
220.4554
Price Sales TTM
0.2971
Enterprise Value EBITDA
2.4575
Price Book MRQ
15.098
Financials SEEL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SEEL
For 52 weeks
0.82 USD
698.88 USD
50 Day MA
2.94 USD
Shares Short Prior Month
116 894
200 Day MA
41.92 USD
Short Ratio
0.14
Shares Short
170 889
Short Percent
29.52 %
BeatStart